Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 25/10/13 → 31/03/19 |
Funding
- Hoffmann-La Roche Inc.: $7,994.00
Keywords
- Aging & Alzheimers, Biotechnology & Drug Development
A Phase II, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Investigate the Efficacy and Safety of RO4602522 Added to Background Alzheimer¿s Disease Therapy in Patients with Moderate Severity Alzheimer¿s Disease
- Knebl, Janice (PI)